Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women’s health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 775 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube.
At Merck, we firmly believe that the process of improving patient care begins with research. Our company has pushed the boundaries of science since its foundation 125 years ago, with the hope and expectation that advances in scientific knowledge will lead to improved healthcare. Today, we are at the forefront of developing medicines and vaccines for the prevention and treatment of some of the most urgent global health challenges, including more than 30 different cancers, hepatitis C, Alzheimer’s disease, Ebola, antibiotic-resistant “superbugs,” and cardio-metabolic diseases. In Canada, Merck has a unique collaborative research model and actively supports the life science industry’s efforts to accelerate research and innovation. We look forward to the successful continuation of these partnerships.